Antibe Therapeutics Inc(Pre-Merger) ATBPF

Why i am not accumulating

[Duster340]

#1 dead money in the short term maybe a couple of months, #2 #likely to slide lower in the coming weeks, #3 cash can be put to work elsewhere 
glta

[Beanie28]

go away

[MrMugsy]

Ya - I've heard it all before. No one knows which way this goes but the odds are on it going up in the near-term. Cash in the bank means we are in a stronger position - for negotiating and as a company. If I'm an institutional investor and I look at this balance sheet ... much stronger now. Keep the exciting news flowing (still lots availabe) and we're making our way to a US exchange

[crow27]

When you lay it out like that Mugs, makes me want to buy more!!!! Everything you are saying is so true.

[Harper75]

Enjoy your posts Mugsy. Of your list, I hope #6 (US Exchange) is foremost for Dan & Co.  The more eyes on ATE when publishing study results or FDA meeting info, partnerships...etc the more value us shareholders will realize.  IMO

[Goaweigh]

I've been following ATE for quite awhile now, owed it , sold it, bought it all back and more just recently but I've never heard any mention of Covid or Alzheimers or Parkinsons, where does this come from ?  Thanks

[MrMugsy]

Other opportunities for H2S have been listed on ATE's corporate presentations in the past.  Sometines added and sometimes removed.  Just as their old IBD drugs have been listed there in the past and removed (ATB-428 and ATB-429).  Things change quickly here so you may not see those drugs or other future opportunities listed anymore. Keep in mind that Dan also mentioned

[MrMugsy]

Goaweigh ... you also asked about COVID.  I didn't responded to that one. For COVID, you need to refer to the BioPUB conference call when Dan was specificially asked about a COVID trial.  Dan said he wan't able to discuss at this time. Cheers !

[Goaweigh]

I've been thinking about Off label applications, of course we need to get 346 approved first but if it completely buffers any negative effects of the nsaids part of the drug then it becomes an H2S delivery system and not an nsaids delivery system although the nsaids part may have benefits too, depending on the use. For IBD for instance the nsaids, even if effectively buffered may still have a

[MrMugsy]

Exactly Goaweigh !  There are many studies out there and we've posted a bunch here in the past.  Have a look at this COVID one.  Pay close attention to Fig.1 as well for some insights. https://journals.physiology.org/doi/full/10.1152/ajpcell.00187.2020 Hope the above link works.

[Amigo11]

Beautiful Dustbin-you are an idiot so thats perfect